MicroRNA-630 may confer favorable cisplatin-based chemotherapy and clinical outcomes in non-small cell lung cancer by targeting Bcl-2

por Chen, Ming-Jenn, Wu, De-Wei, Wang, Gao-Chang, Wang, Yao-Chen, Chen, Chi-Yi, Lee, Huei
Publicado 2018